Chemours
418 hedge funds and large institutions have $1.96B invested in Chemours in 2019 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 116 increasing their positions, 153 reducing their positions, and 113 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
418
Holders Change
-69
Holders Change %
-14.17%
% of All Funds
9.18%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.11%
New
46
Increased
116
Reduced
153
Closed
113
Calls
$25.9M
Puts
$90.6M
Net Calls
-$64.7M
Net Calls Change
-$21.4M
Top Buyers
| 1 |
1
Norges Bank
Oslo,
Norway
|
$98M |
| 2 |
SC
2
Sessa Capital
New York
|
$103M |
| 3 |
GC
3
Greenlight Capital
New York
|
$96.9M |
| 4 |
MWA
4
Marshall Wace Asia
Central,
Hong Kong
|
$28M |
| 5 |
5
Fidelity Investments
Boston,
Massachusetts
|
$365M |
Top Sellers
| 1 |
TP
1
Third Point
New York
|
$0 |
| 2 |
CS
2
Credit Suisse
Zurich,
Switzerland
|
$3.51M |
| 3 |
3
BlackRock
New York
|
$215M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$59.4M |
| 5 |
5
Goldman Sachs
New York
|
$19.5M |
